Published in Gene Therapy Weekly, October 2nd, 2003
This patent serves to broaden Diversa's intellectual property position covering its technologies for discovering novel molecules from the over 99% of microbial diversity that has not been previously accessed for product development. From this previously untapped natural resource, Diversa is discovering novel product candidates using technologies including genomic methods for accessing microbial DNA, high-throughput microbial culturing, and robotic systems capable of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.